Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-β in ovarian carcinoma cells BH Morrison, JA Bauer, DV Kalvakolanu, DJ Lindner Journal of Biological Chemistry 276 (27), 24965-24970, 2001 | 190 | 2001 |
Suppression of NF-κB survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL M Chawla-Sarkar, JA Bauer, JA Lupica, BH Morrison, Z Tang, RK Oates, ... Journal of Biological Chemistry 278 (41), 39461-39469, 2003 | 97 | 2003 |
Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics BH Morrison, JA Bauer, J Hu, RW Grane, AM Ozdemir, M Chawla-Sarkar, ... Oncogene 21 (12), 1882-1889, 2002 | 85 | 2002 |
Immunohistochemical quantification of the vitamin B12 transport protein (TCII), cell surface receptor (TCII-R) and Ki-67 in human tumor xenografts AM Sysel, VE Valli, RB Nagle, JA Bauer Anticancer research 33 (10), 4203-4212, 2013 | 79 | 2013 |
Effects of interferon β on transcobalamin II-receptor expression and antitumor activity of nitrosylcobalamin JA Bauer, BH Morrison, RW Grane, BS Jacobs, S Dabney, AM Gamero, ... Journal of the National Cancer Institute 94 (13), 1010-1019, 2002 | 79 | 2002 |
Nitrosylcobalamin promotes cell death via S nitrosylation of Apo2L/TRAIL receptor DR4 Z Tang, JA Bauer, B Morrison, DJ Lindner Molecular and cellular biology, 2006 | 76 | 2006 |
Interactions of cubilin with megalin and the product of the amnionless gene (AMN): effect on its stability R Ahuja, R Yammani, JA Bauer, S Kalra, S Seetharam, B Seetharam Biochemical Journal 410 (2), 301-308, 2008 | 68 | 2008 |
Evaluation of linear polyethyleneimine/nitric oxide adduct on wound repair: therapy versus toxicity JA Bauer, W Rao, DJ Smith Wound Repair and Regeneration 6 (6), 569-577, 1998 | 66 | 1998 |
Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-β-induced apoptosis in ovarian carcinoma BH Morrison, Z Tang, BS Jacobs, JA Bauer, DJ Lindner Biochemical Journal 385 (2), 595-603, 2005 | 47 | 2005 |
IFN-α2b and Thalidomide Synergistically Inhibit Tumor-Induced Angiogenesis JA Bauer, BH Morrison, RW Grane, BS Jacobs, EC Borden, DJ Lindner Journal of interferon & cytokine research 23 (1), 3-10, 2003 | 40 | 2003 |
Synthesis, characterization and nitric oxide release profile of nitrosylcobalamin: a potential chemotherapeutic agent JA Bauer Anti-cancer drugs 9 (3), 239-244, 1998 | 38 | 1998 |
Immunohistochemical quantification of the cobalamin transport protein, cell surface receptor and Ki-67 in naturally occurring canine and feline malignant tumors and in adjacent … AM Sysel, VE Valli, JA Bauer Oncotarget 6 (4), 2331, 2014 | 30 | 2014 |
Nitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signaling JA Bauer, JA Lupica, H Szugye, BH Morrison, RM Haney, RK Masci, ... PLoS One 2 (12), e1313, 2007 | 29 | 2007 |
Effect of inositol hexakisphosphate kinase 2 on transforming growth factor β-activated kinase 1 and NF-κB activation BH Morrison, JA Bauer, JA Lupica, Z Tang, H Szugye, JA DiDonato, ... Journal of Biological Chemistry 282 (21), 15349-15356, 2007 | 26 | 2007 |
Metallocorrinoids as biologically compatible carriers of pharmacological agents JA Bauer US Patent 5,936,082, 1999 | 24 | 1999 |
Anti-tumor effects of nitrosylcobalamin against spontaneous tumors in dogs JA Bauer, G Frye, A Bahr, J Gieg, P Brofman Investigational new drugs 28, 694-702, 2010 | 23 | 2010 |
Composition and methods for affecting metallocorrinoid uptake JA Bauer, DJ Lindner US Patent 6,752,986, 2004 | 13 | 2004 |
Hydroxocobalamins as biologically compatible donors of nitric oxide implicated in the acceleration of wound healing JA Bauer Medical hypotheses 51 (1), 65-67, 1998 | 13 | 1998 |
Treatment of breast cancer with silver antitumor drugs encapsulated in biodegradable polymeric nanoparticles WJ Youngs, N Robishaw, MJ Panzner, K Hindi, DA Medvetz, J Youngs, ... Nanotech Conference & Expo 2, 5-8, 2009 | 11 | 2009 |
Antimicrobial properties of diethylamine NONOate, a nitric oxide donor, against Escherichia coli: a pilot study AM Sysel, MJ Dunphy, JA Bauer The Journal of Antibiotics 74 (4), 260-265, 2021 | 10 | 2021 |